PACIFIC EDGE LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.082 NZD | -2.38% |
|
-3.53% | -29.91% |
| Apr. 09 | Pacific Edge Reports Steady Growth in Bladder Cancer Test Volumes in Fiscal Q4 | MT |
| Mar. 14 | New Zealand Shares Flat on Thursday; Pacific Edge's Chair to Retire | MT |
Presenter SpeechPeter Meintjes (Executives)Good morning, everybody, and welcome to the Pacific...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Pacific Edge Limited is a global cancer diagnostics company. The Company is engaged in the development and commercialization of bladder cancer diagnostic and prognostic tests for patients presenting with hematuria or surveillance of recurrent disease. The Company operates through two segments: Commercial and Research. The Commercial segment is engaged in the sales, marketing, laboratory, and support operations to run the commercial businesses worldwide. The Research segment is engaged in the research and development of diagnostic and prognostic products for human cancer. The Company provides its suite of Cxbladder tests globally through its wholly owned laboratories in New Zealand and the United States. Its Cxbladder tests assist clinicians to safely de-intensify hematuria evaluation from low incidence populations; resolve diagnostic dilemmas, and monitor patients for the recurrence of urothelial carcinoma. It operates in New Zealand, Australia, Singapore, and the United States.
Calendar
2024-05-29
- Q4 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
0.082
NZD
Average target price
0.135
NZD
Spread / Average Target
+64.63%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -29.91% | 39.47M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- PEB Stock
- News Pacific Edge Limited
- Transcript : Pacific Edge Limited, 2023 Earnings Call, May 25, 2023
